Wellington Management Ups Merck Stake, Reduces Pfizer Q3 Stock Holding Wall St. Cheat Sheet The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. Forest Laboratories Inc. (NYSE:FRX): On 06/30/2011 reported ... |
